$35.70
-0.29[-0.81%]
At close: May 14
$35.70
0[0.00%]
After Hours: 4:00PM EDT
Structure Therapeutics
(NASDAQ:GPCR)Latest News for Structure Therapeutics Stock (NASDAQ:GPCR)
Structure Therapeutics Stock (NASDAQ: GPCR)
Categories: All
Friday, May 10, 2024
Thursday, May 09, 2024
Friday, May 03, 2024
Thursday, April 18, 2024
Tuesday, April 09, 2024
Friday, March 08, 2024
Tuesday, December 19, 2023
Monday, December 18, 2023
- Nasdaq Gains 100 Points; Biomerica Shares Spike HigherAvi Kapoor - Dec 18, 2023, 2:21PM
- Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Dec 18, 2023, 1:05PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Dec 18, 2023, 12:32PM
- Crude Oil Rises 3%; US Housing Market Index Increases In DecemberAvi Kapoor - Dec 18, 2023, 12:17PM
- Why Is Novo Nordisk's Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today?Vandana Singh - Dec 18, 2023, 11:20AM
- Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. SteelAvi Kapoor - Dec 18, 2023, 9:51AM
- Structure Therapeutics shares are trading lower after the company announced a comprehensive development program update for GSBR-1290.Benzinga Newsdesk - Dec 18, 2023, 9:04AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Dec 18, 2023, 8:08AM
- Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyBenzinga Newsdesk - Dec 18, 2023, 7:35AM
Monday, November 20, 2023
Wednesday, November 15, 2023
Tuesday, November 14, 2023
Thursday, October 26, 2023
Thursday, October 19, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023Benzinga Insights - Oct 19, 2023, 11:06AM
- 4 Analysts Have This to Say About Structure TherapeuticsBenzinga Insights - Oct 19, 2023, 9:00AM
- JMP Securities Initiates Coverage On Structure Therapeutics with Market Outperform Rating, Announces Price Target of $90Benzinga Newsdesk - Oct 19, 2023, 7:14AM
Tuesday, October 03, 2023
Friday, September 29, 2023
- Jefferies Maintains Buy on Structure Therapeutics, Raises Price Target to $79Benzinga Newsdesk - Sep 29, 2023, 2:29PM
- Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Sep 29, 2023, 2:09PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Sep 29, 2023, 1:31PM
- Nasdaq Gains Over 1%; Nike Posts Upbeat EarningsLisa Levin - Sep 29, 2023, 10:16AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Sep 29, 2023, 9:05AM
- Structure Therapeutics shares are trading higher after the company announced results from its Phase 1b clinical study of oral GLP-1 receptor agonist GSBR-1290 and provided a program update.Benzinga Newsdesk - Sep 29, 2023, 9:01AM
- Why Is Obesity Focused Structure Therapeutics Stock Trading Higher Today?Vandana Singh - Sep 29, 2023, 8:55AM
- Market-Moving News for September 29thBenzinga Newsdesk - Sep 29, 2023, 8:42AM
- Structure Therapeutics Announced A Private Placement Of 21.6M Shares And 2.4M Newly Designated Non-voting Shares At $12.49/Share, With Gross Proceeds Of Approximately $300MBenzinga Newsdesk - Sep 29, 2023, 7:37AM
- Structure Therapeutics' Phase 1b Multiple Ascending Dose Study Of Its GSBR-1290, In Healthy Overweight Or Obese Individuals. Demonstrated Significant Weight Loss Supporting Once-daily Dosing And An Encouraging Safety And Tolerability ProfileBenzinga Newsdesk - Sep 29, 2023, 7:33AM